PortfoliosLab logo

Adverum Biotechnologies, Inc. (ADVM)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS00773U1088
CUSIP00773U108
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.06
Year Range$0.81 - $3.60
EMA (50)$1.04
EMA (200)$1.64
Average Volume$1.15M
Market Capitalization$104.70M

ADVMShare Price Chart


Chart placeholderClick Calculate to get results

ADVMPerformance

The chart shows the growth of $10,000 invested in Adverum Biotechnologies, Inc. on Aug 1, 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $379 for a total return of roughly -96.21%. All prices are adjusted for splits and dividends.


ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)

ADVMReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M19.37%-6.21%
YTD-39.77%-18.17%
6M-43.32%-17.47%
1Y-72.25%-8.89%
5Y-17.08%10.04%
10Y-33.94%9.31%

ADVMMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ADVMSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Adverum Biotechnologies, Inc. Sharpe ratio is -1.18. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)

ADVMDividend History


Adverum Biotechnologies, Inc. doesn't pay dividends

ADVMDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)

ADVMWorst Drawdowns

The table below shows the maximum drawdowns of the Adverum Biotechnologies, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Adverum Biotechnologies, Inc. is 98.65%, recorded on May 16, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.65%Jan 8, 20151852May 16, 2022
-19.26%Aug 1, 20143Aug 5, 20149Aug 18, 201412
-17.74%Sep 30, 20149Oct 10, 201417Nov 4, 201426
-12.89%Sep 15, 20145Sep 19, 20145Sep 26, 201410
-10.31%Nov 5, 201411Nov 19, 20144Nov 25, 201415
-8.51%Dec 23, 20142Dec 24, 20142Dec 29, 20144
-8.47%Jan 6, 20151Jan 6, 20151Jan 7, 20152
-7.31%Aug 21, 20144Aug 26, 201411Sep 11, 201415
-5.55%Nov 28, 20142Dec 1, 20142Dec 3, 20144
-3.38%Dec 31, 20141Dec 31, 20141Jan 2, 20152

ADVMVolatility Chart

Current Adverum Biotechnologies, Inc. volatility is 39.93%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)

Portfolios with Adverum Biotechnologies, Inc.


Loading data...